Welcome to our dedicated page for Quantum-Si Incorporated SEC filings (Ticker: QSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum-Si Incorporated filings document the formal disclosures of a Nasdaq-listed proteomics technology company developing single-molecule protein sequencing systems. Form 8-K reports furnish financial results, business updates, Regulation FD presentations and material agreements tied to the company’s operations and capital markets activity.
The filing record also covers annual-meeting proxy matters, board and compensation governance, executive and equity-award disclosure, Class A common stock, and redeemable warrants listed under QSIAW. Material-event filings document sales-agreement and shelf-registration disclosures for potential Class A common stock issuance, as well as lease-related settlement and termination matters.
Quantum-Si CFO Jeffry R. Keyes reported a sale of 8,624 shares of Class A Common Stock on June 23, 2025, at a weighted average price of $1.6139 per share. The transaction was executed through a mandatory sell-to-cover provision to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs).
Key details of the transaction:
- The sales prices ranged from $1.55 to $1.68 per share
- Following the transaction, Keyes retains beneficial ownership of 1,179,570 shares held directly
- The sale was automatic and non-discretionary, triggered by RSU vesting tax obligations
- The Form 4 was filed on behalf of Keyes by Christian LaPointe, Ph.D., as attorney-in-fact